XML 25 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Changes in Stockholders' Equity (Deficit) and Comprehensive Loss - USD ($)
Preferred Stock [Member]
Series F Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Series F Preferred Stock [Member]
Total
Balance at Dec. 31, 2022 $ 6 $ 88,467 $ 154,679,363 $ 10,083 $ (111,553,444)   $ 43,224,475
Balance, shares at Dec. 31, 2022 5,863 88,466,613          
Effect on existing shares due to Reverse Split on February 9, 2024 $ (84,043) 84,043  
Effect on existing shares due to Reverse Split on February 9, 2024, shares   (84,043,282)          
Effect on existing shares due to Reverse Split on October 14, 2024   $ (4,335) 4,335  
Effect on existing shares due to Reverse Split on October 14, 2024, shares   (4,334,864)          
Issuance of Preferred Stock, Series F Convertible, net of issuance cost $ 5 4,674,995   4,675,000
Issuance of Preferred Stock, Series F Convertible, net of issuance cost, shares 4,850            
Conversion of Preferred Stock, Series F Convertible shares to Common Stock $ (5) $ 28 (23)  
Conversion of Preferred Stock, Series F Convertible shares to Common Stock, shares (4,638) 27,805       4,638  
Dividends on Series F Preferred Stock (339,631)   (339,631)
Deemed dividend on Series F Preferred Stock 11,607,910 (11,607,910)  
Sale of Common Stock, net of issuance costs $ 18 3,967,382   3,967,400
Sale of Common Stock, net of issuance costs, shares   18,220          
Conversion of warrants issued with promissory note and incremental value modification $ 5 190,495   190,500
Conversion of warrants issued with promissory note and incremental value modification, shares   5,000          
Issuance of Restricted Common Stock $ 1 (1)  
Issuance of Restricted Common Stock, shares   1,029          
Stock-based compensation expense 1,305,329   1,305,329
Amortization of unrecognized periodic pension costs (244,323)   (244,323)
Foreign currency cumulative translation adjustment 340,543   340,543
Net loss (42,421,737)   $ (42,421,737)
Exercise of warrants issued with Series F, shares            
Balance at Dec. 31, 2023 $ 6 $ 141 176,174,197 106,303 (165,583,091)   $ 10,697,556
Balance, shares at Dec. 31, 2023 6,075 140,521          
Issuance of Preferred Stock, Series F Convertible, net of issuance cost $ 6 4,774,994   4,775,000
Issuance of Preferred Stock, Series F Convertible, net of issuance cost, shares 6,350            
Conversion of Preferred Stock, Series F Convertible shares to Common Stock $ (6) $ 201 (195)  
Conversion of Preferred Stock, Series F Convertible shares to Common Stock, shares (6,490) 200,645       6,490  
Dividends on Series F Preferred Stock (234,439)   (234,439)
Issuance of Restricted Common Stock  
Issuance of Restricted Common Stock, shares   688          
Stock-based compensation expense 80,606   80,606
Amortization of unrecognized periodic pension costs 10,246   10,246
Foreign currency cumulative translation adjustment (202,925)   (202,925)
Net loss (35,041,673)   (35,041,673)
Fractional effect on existing shares due to Reverse Split on October 14, 2024  
Fractional effect on existing shares due to Reverse Split on October 14, 2024, shares   321          
Conversion of Convertible Note principal to Common Stock $ 2 99,998   100,000
Conversion of Convertible Note principal to Common Stock, shares   1,597          
Exercise of warrants issued with Series F $ 17 497,684   $ 497,701
Exercise of warrants issued with Series F, shares   16,590        
Reduction of Conversion Price on Convertible Note 6,351,221   $ 6,351,221
Debt Extinguishment on modification of Convertible Note 1,572,512   1,572,512
Deemed dividend on Series F Preferred Stock and Series F Warrants 17,756,454 (17,756,454)  
Sale of Common Stock and warrant liabilties, net of issuance costs $ 538 (538)  
Sale of Common Stock and warrant liabilties, net of issuance costs, shares   538,000          
Legal fees incurred on financing activities (615,082)   (615,082)
Alternate Cashless Exercise of Series A Warrants $ 6,309 (6,309)  
Alternate Cashless Exercise of Series A Warrants, shares   6,309,074          
Exercise of Series B Warrants $ 2,454 4,764,864   4,767,318
Exercise of Series B Warrants, shares   2,454,228          
Issuance Cost on Series F as consideration for Omnibus Agreement 1,500,000   1,500,000
Balance at Dec. 31, 2024 $ 6 $ 9,662 $ 212,715,967 $ (86,376) $ (218,381,218)   $ (5,741,959)
Balance, shares at Dec. 31, 2024 5,935 9,661,664